eFFECTOR Therapeutics, Inc.

CIK 1828522 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for eFFECTOR Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 1, 2024EFFECT9999999995-24-002348
Aug 1, 2024EFFECT9999999995-24-002349
Aug 1, 2024EFFECT9999999995-24-002352
Aug 1, 2024EFFECT9999999995-24-002347
Jul 30, 202415-12G0001193125-24-188900
Jul 30, 2024S-8 POS0001193125-24-188875
Jul 30, 2024POS AM0001193125-24-188868
Jul 30, 2024POS AM0001193125-24-188859
Jul 30, 2024POS AM0001193125-24-188836
Jul 30, 2024S-8 POS0001193125-24-188897
Jul 30, 2024POS AM0001193125-24-188848
Jul 19, 202425-NSE0001354457-24-000516
Jun 26, 20248-K0000950170-24-077530
Jun 25, 20248-K0000950170-24-077420
Jun 24, 20248-K0001193125-24-166275
Jun 14, 20248-K0001193125-24-161574
Jun 13, 202440000950170-24-073199
Jun 13, 202440000950170-24-073209
Jun 13, 202440000950170-24-073195
Jun 13, 202440000950170-24-073213
Jun 13, 202440000950170-24-073202
Jun 13, 202440000950170-24-073204
May 20, 20248-K0001193125-24-142277
May 17, 20248-K0001193125-24-141847
May 17, 202440000950170-24-061597